Myeloproliferative Neoplasms (MPN) Latest Advances

Roles of megakaryocytes and platelets in myeloproliferative neoplasms.

Journal: Current opinion in hematology

Published: June 17, 2026

ST-segment elevation myocardial infarction as the first manifestation of JAK2-positive myeloproliferative neoplasm in a young man.

Journal: Kardiologia polska

Published: June 17, 2026

Myeloproliferative neoplasm with a homozygous germline SH2B3 mutation: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: May 20, 2026

Incidence, Prevalence, and Survival Outcomes of Patients with Myeloproliferative Neoplasms in the United States: a SEER database analysis, years 2000-2021.

Journal: Research square

Published: May 18, 2026

Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

Journal: Thrombosis and haemostasis

Published: May 13, 2026

Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm."

Journal: Haematologica

Published: May 11, 2026

Prognostic Scores and Risk Stratification of Myeloproliferative Neoplasms: 2026 Updates.

Journal: Cancers

Published: May 05, 2026

Myeloproliferative Neoplasms, Clonal Thrombosis, and Vascular Disease: Can Cardiology Learn from Hematology?

Journal: Cardiology in review

Published: April 30, 2026

Artificial intelligence triage tool for bone marrow fibrosis in myeloproliferative neoplasms using complete blood counts.

Journal: The Lancet. Haematology

Published: April 29, 2026

Hyperplasia, dysplasia and neoplasia are unique pathological entities. Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm".

Journal: Haematologica

Published: April 28, 2026

Proteomics as a Theranostic Compass in BCR::ABL1-Negative Myeloproliferative Neoplasms: Integrating Biomarker Discovery with Therapeutic Stratification.

Journal: Critical reviews in oncology/hematology

Published: April 28, 2026

Liver and Spleen Point Shear-Wave Elastography in Newly Diagnosed BCR::ABL1-Negative Myeloproliferative Neoplasms: Associations with Hematologic Parameters and Bone Marrow Fibrosis Grade - A Prospective Cross-Sectional Study.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: April 27, 2026

Myeloproliferative Neoplasms (MPN) Latest Advances

Find the Latest Research About Myeloproliferative Neoplasms (MPN)

Roles of megakaryocytes and platelets in myeloproliferative neoplasms.

Roles of megakaryocytes and platelets in myeloproliferative neoplasms.

ST-segment elevation myocardial infarction as the first manifestation of JAK2-positive myeloproliferative neoplasm in a young man.

ST-segment elevation myocardial infarction as the first manifestation of JAK2-positive myeloproliferative neoplasm in a young man.

Myeloproliferative neoplasm with a homozygous germline SH2B3 mutation: a case report and literature review

Myeloproliferative neoplasm with a homozygous germline SH2B3 mutation: a case report and literature review

Incidence, Prevalence, and Survival Outcomes of Patients with Myeloproliferative Neoplasms in the United States: a SEER database analysis, years 2000-2021.

Incidence, Prevalence, and Survival Outcomes of Patients with Myeloproliferative Neoplasms in the United States: a SEER database analysis, years 2000-2021.

Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm."

Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm."

Prognostic Scores and Risk Stratification of Myeloproliferative Neoplasms: 2026 Updates.

Prognostic Scores and Risk Stratification of Myeloproliferative Neoplasms: 2026 Updates.

Myeloproliferative Neoplasms, Clonal Thrombosis, and Vascular Disease: Can Cardiology Learn from Hematology?

Myeloproliferative Neoplasms, Clonal Thrombosis, and Vascular Disease: Can Cardiology Learn from Hematology?

Artificial intelligence triage tool for bone marrow fibrosis in myeloproliferative neoplasms using complete blood counts.

Artificial intelligence triage tool for bone marrow fibrosis in myeloproliferative neoplasms using complete blood counts.

Hyperplasia, dysplasia and neoplasia are unique pathological entities. Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm".

Hyperplasia, dysplasia and neoplasia are unique pathological entities. Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm".

Proteomics as a Theranostic Compass in BCR::ABL1-Negative Myeloproliferative Neoplasms: Integrating Biomarker Discovery with Therapeutic Stratification.

Proteomics as a Theranostic Compass in BCR::ABL1-Negative Myeloproliferative Neoplasms: Integrating Biomarker Discovery with Therapeutic Stratification.

Liver and Spleen Point Shear-Wave Elastography in Newly Diagnosed BCR::ABL1-Negative Myeloproliferative Neoplasms: Associations with Hematologic Parameters and Bone Marrow Fibrosis Grade - A Prospective Cross-Sectional Study.

Liver and Spleen Point Shear-Wave Elastography in Newly Diagnosed BCR::ABL1-Negative Myeloproliferative Neoplasms: Associations with Hematologic Parameters and Bone Marrow Fibrosis Grade - A Prospective Cross-Sectional Study.